In FY 2025, the FDA completed 3,732 inspections of registered drug and medical device establishments worldwide, including quality system inspections for Class II and Class III devices. As the agency expands unannounced inspections at foreign facilities, companies can no longer treat FDA medical devices registration as a simple administrative step. Instead, manufacturers must align device classification, 510(k) clearance, Manufacturers must align device classification, 510(k) clearance, device listing, and quality controls before entering the U.S. market. Therefore, this guide explains each requirement and highlights the compliance gaps that may delay market access or trigger regulatory action.
Table of Contents
What Is FDA Medical Devices Registration?
FDA medical devices registration includes establishment registration and device listing. However, these steps do not provide FDA clearance, approval, or legal permission to sell. Instead, companies must follow the correct pathway, such as 510(k), De Novo, or Premarket Approval, based on the device’s classification and risk level.
Why Accurate Registration Records Matter During FDA Inspection?
FDA investigators may compare registration records with product codes, premarket numbers, labeling, import data, and quality documents. Therefore, accurate records help companies avoid inspection findings, import delays, and market-access risks.
Four Decisions That Determine FDA Market Entry
The following four decisions shape your device’s regulatory pathway, registration duties, and readiness for the U.S. market:
- Classification and Product Code Selection (PDF)
- Selecting the Correct Premarket Pathway (PDF)
- Establishment Registration and Device Listing (PDF)
- Foreign Establishments and Annual Renewal (PDF)
The infographic below shows how device identity, classification, premarket authorization, establishment registration, and listing work together to support legal distribution in the U.S. market.
Classification and Product Code Selection (PDF)
FDA classifies each medical device according to its intended use, risk level, and applicable regulatory controls. Therefore, manufacturers must select the correct three-letter product code because it affects premarket review, device listing, import screening, and postmarket reporting.
Selecting the Correct Premarket Pathway (PDF)
Device classification helps manufacturers determine whether they need a 510(k), De Novo request, PMA, or another submission pathway. Moreover, each pathway follows different evidence requirements, review processes, timelines, and regulatory standards.
Establishment Registration and Device Listing (PDF)
Manufacturers must register each qualifying establishment and list the devices and activities connected to that location. In addition, companies must link non-exempt listings to the correct premarket submission number and maintain consistent product information in FDA systems.
Foreign Establishments and Annual Renewal (PDF)
Foreign establishments must register and list qualifying devices before they first export them to the United States. Furthermore, establishments must review and renew their registration and listing information annually between October 1 and December 31 while reporting necessary changes.
How the FDA Registration Process Works in FURLS
The FDA medical device registration process starts when the establishment pays the annual user fee and receives its PIN and PCN. Next, the owner or official correspondent accesses FURLS, opens the Device Registration and Listing Module, registers the establishment, and lists each device with the correct product and premarket information. Finally, the company should verify the completed records because FDA does not consider registration complete until it applies the payment numbers in FURLS.
Registration Gaps That Create Inspection and Import Risk
Small inconsistencies can turn FDA medical device registration into a serious market-access risk. FDA systems compare establishment records, device listings, product descriptions, premarket numbers, and import data. Moreover, investigators may verify whether these records match the company’s actual products and manufacturing activities; therefore, unresolved gaps can trigger document requests, shipment detention, refusal, or deeper inspection review.
The table below highlights the registration gaps that companies should identify and correct before an inspection or U.S. import entry:
| Registration Gap | Typical Inconsistency | Potential Risk | Recommended Control |
|---|---|---|---|
|
Inactive establishment registration |
FURLS shows an expired or inactive facility |
Shipment detention, entry refusal, or registration questions |
Confirm active status and complete annual renewal before shipping. |
|
Missing or incorrect device listing |
The device listing does not match the product or manufacturer |
Import delays, document requests, or failed FDA database checks |
Verify each listing and connect it to the correct device and establishment. |
|
Manufacturer record mismatch |
Names, addresses, or registration numbers differ across FDA and import records |
FDA may fail to match the shipment with the registered establishment |
Standardize legal names, addresses, FEI numbers, and registration details. |
|
Product code or premarket number mismatch |
The product code, 510(k), De Novo, or PMA number does not match the imported device |
Detention, refusal, or questions about legal market authorization |
Confirm classification and link each device to the correct product code and premarket record. |
The infographic below shows where inconsistent FDA records can create inspection findings, import delays, and market-access risks.
Final Words
In FY 2025, FDA conducted 355 for-cause inspections across drug and device establishments, showing how complaints and suspected quality problems can trigger targeted regulatory action. Therefore, manufacturers should treat FDA medical devices registration as an active compliance process and keep classification, listing, labeling, premarket, and manufacturing records accurate and inspection-ready.
Medical Devices & IVDs EU Registration
We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.
FAQ
Yes. FDA may still detain the shipment if the device listing, product code, premarket number, labeling, or manufacturer information does not match FDA records.
Investigators may compare FURLS data with device listings, 510(k) or PMA numbers, labels, import records, manufacturing activities, and controlled quality documents.
Companies should review their records before every shipment, after any product or facility change, and during the annual registration renewal period.
References
Alireza Zarei is the founder and CEO of Zamann Pharma Support GmbH in Germany. He pairs 20 years in GMP—beginning in a lab in 2005—with front-line global project delivery for companies such as Boehringer Ingelheim, Roche, BioNTech, Takeda, Fresenius Medical Care, Biotest, ratiopharm and others. He focuses on innovative validation and qualification procedures, master data management strategies, end-to-end LIMS implementation and care, with pragmatic advice on general Quality Management topics and management level OpEx consulting. Together with his team he also created Pharmuni.com as the leading GMP learning platform in the industry.